Ríos Rull P, Rodríguez Pérez A, Ibáñez García A, Arrieta R, De la Cámara C
Servicio de Hematología y Hemoterapia, Hospital La Paz, Madrid.
Sangre (Barc). 1992 Jun;37(3):197-9.
A 54 year-old woman subjected to renal transplant with minor ABO incompatibility developed clinically severe anti-AB haemolytic anaemia. On the 13th day after transplantation the patient had: haemoglobin, 7.5 g/dL, unconjugated bilirubin, 393 mumol/L (23 mg/dL), and undetectable haptoglobin levels. Positive direct antihuman globulin test was found, and an IgG antibody capable of binding complement and with anti-AB specificity was found upon studying the eluate. Immunosuppressive therapy improved the clinical picture, although antibodies could still be detected one month later. Clinically significant immune haemolysis after renal transplantation appears in about 10-15% of those cases having antibodies against the host's antigens. The peak red-cell destruction is seen one to two weeks after grafting, and haemolytic signs may last for about three weeks. Although self-limited, this condition may achieve high severity. The duration and severity of haemolysis depend upon the density of antigen sites on the surface of the host's red-cells, his secretor trait, the presence or absence of complement activation and the immunosuppressive therapy including cyclosporin. Several cases of anti-A and anti-B specificity have been reported, but anti-AB specificity had not been previously found; this fact is probably related to the scarce interest paid to its search thus far.
一名54岁接受了轻微ABO血型不相容肾移植的女性出现了临床严重的抗AB溶血性贫血。移植后第13天,患者的血红蛋白为7.5g/dL,非结合胆红素为393μmol/L(23mg/dL),触珠蛋白水平检测不到。直接抗人球蛋白试验呈阳性,对洗脱液进行研究时发现了一种能够结合补体且具有抗AB特异性的IgG抗体。免疫抑制治疗改善了临床症状,尽管一个月后仍能检测到抗体。肾移植后临床上显著的免疫溶血出现在约10%至15%具有针对宿主抗原抗体的病例中。红细胞破坏高峰出现在移植后一至两周,溶血体征可能持续约三周。尽管这种情况具有自限性,但可能会达到很高的严重程度。溶血的持续时间和严重程度取决于宿主红细胞表面抗原位点的密度、其分泌型特征、补体激活的有无以及包括环孢素在内的免疫抑制治疗。已经报道了几例抗A和抗B特异性的病例,但此前尚未发现抗AB特异性;这一事实可能与迄今为止对其研究的关注度较低有关。